-transparent.png){kind=logo}
Female Wistar rats have been injected intravenously for seven days with various different doses of silybin, the main component of the drug silymarin, and the in vitro synthesis of phosphatidylethanolamine and phosphatidylcholine from their respective precursors, CDP-ethanolamine and CDP-choline has been examined in liver microsomal membranes. Appreciable inhibition of the incorporation rates of precursors into lipids has been noticed at dosage of 15-20 mg/100 g body wt., daily. No evident effect is exerted by similar silybin treatment on choline and ethanolamine incorporation respectively into liver phosphatidylcholine and phosphatidylethanolamine in vivo.
Related Publications
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
January 1976,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
May 1973,
Biochemical and biophysical research communications,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
January 1979,
Arzneimittel-Forschung,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
July 1989,
Cell biochemistry and function,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
July 1969,
Biochimica et biophysica acta,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
October 1975,
Arzneimittel-Forschung,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
January 1977,
Arzneimittel-Forschung,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
February 1977,
Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
September 2007,
Digestive diseases and sciences,
I Montanini, and
E Castigli, and
U G Arienti, and
G Porcellati
February 1985,
FEBS letters,
